fusidic acid has been researched along with mbx 1090 in 1 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (mbx 1090) | Trials (mbx 1090) | Recent Studies (post-2010) (mbx 1090) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 5 | 0 | 3 |
| Protein | Taxonomy | fusidic acid (IC50) | mbx 1090 (IC50) |
|---|---|---|---|
| Decaprenyl diphosphate synthase | Mycobacterium tuberculosis CDC1551 | 0.49 | |
| Tuberculosinyl adenosine transferase | Mycobacterium tuberculosis CDC1551 | 0.66 | |
| Short-chain Z-isoprenyl diphosphate synthase | Mycobacterium tuberculosis variant bovis AF2122/97 | 4.8 | |
| Protein arginine N-methyltransferase 1 | Homo sapiens (human) | 6.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
1 other study(ies) available for fusidic acid and mbx 1090
| Article | Year |
|---|---|
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |